NCT06116773 is a NA clinical trial of Training in Coronary Artery Disease, sponsored by Istanbul University - Cerrahpasa.

Who is sponsoring NCT06116773?

NCT06116773 is sponsored by Istanbul University - Cerrahpasa.

What drugs are being tested in NCT06116773?

Interventions in NCT06116773: Training, Control.

What condition does NCT06116773 study?

NCT06116773 studies Coronary Artery Disease.

Is NCT06116773 still recruiting?

NCT06116773 is currently status unknown. Last updated 11 December 2023.

Last reviewed 2023-12-11 · How we verify

NCT06116773

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Early Cardiac Rehabilitation

Status unknown NA Last updated 11 December 2023

What this trial tests

NA trial testing Training in Coronary Artery Disease in 50 participants. Status unknown.

Timeline

1 December 2023

Primary endpoint
1 July 2025

1 December 2025

Quick facts

Lead sponsor	Istanbul University - Cerrahpasa
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	1 December 2023
Primary completion	1 July 2025
Estimated completion	1 December 2025
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Training
Control

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →

Sponsor

Istanbul University - Cerrahpasa

Who can join

Adults 65 to 95, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this experimental study is to compare the effects of early (2nd week) cardiac rehabilitation applied in addition to usual care on functional capacity, quality of life, frailty and body composition in patients undergoing coronary artery bypass graft surgery. The main questions it aims to answer are: * Does early cardiac rehabilitation contribute to increasing functional capacity? * Does early cardiac rehabilitation have positive effects on quality of life, frailty and body composition? Participants will be divided into 2 groups (n = 50) in a randomized controlled manner. Patients in the training group (n:25) will participate in an 8-week supervised cardiac rehabilitation program as an outpatient after discharge. Patients in the control group (n:25) will be provided with usual care after discharge. The control group will be informed about secondary prevention approaches and a home-based exercise program will be recommended. In addition to secondary prevention approaches and home-based exercise program, the training group will receive 3 sessions/week, 60 minutes of supervised cardiac rehabilitation for 8 weeks. All patients will be evaluated at baseline and after 8 weeks. Researchers will compare training and control groups to see if effects on functional capacity, quality of life, frailty, body composition

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Training

Trials testing the same drug.

NCT07379073 — Evaluation of a Clinical Support Website for the Management of Common Mental Health Conditions in Primary Care on Compli · NA · not yet recruiting
NCT06961942 — Enhancing Endoscopic Scoring Consistency and Accuracy in IBD: a Video-based Training Approach · NA · not yet recruiting
NCT07202182 — Creative Drama-Based Stress Management Program on Stress, Coping, and Emotional Intelligence · NA · completed
NCT07533838 — The Effect of Simulation-Based ECG Training on ECG Reading Skills of Nursing Students · NA · completed
NCT06849440 — Effectiveness of Childbirth Preparation Education · NA · completed

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

NCT07588685 — Validity and Reliability of the Turkish Form of the Enjoyment of Physical Activity Scale-8 in Geriatrics With Minimal Co · not yet recruiting
NCT07370025 — The Effect of Lullaby During Bath Time on Mother-Infant Bonding, Postpartum Depression, and Parental Self-Efficacy in In · NA · not yet recruiting
NCT07378449 — The Effect of Hand Exercise Hoops on Labour Pain · NA · not yet recruiting
NCT07293000 — Evaluating Two Nursing Interventions to Prevent Urinary Retention After Spinal Anesthesia · NA · not yet recruiting
NCT07562880 — Validity and Reliability of the Exercise-Related Health Beliefs Attitude Scale in Geriatric Individuals · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06116773 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul University - Cerrahpasa
Last refreshed: 11 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06116773.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing